TILT Biotherapeutics tiltbio.com


Public list: Pharma Startups (4732) Healthcare Horizons (27) Cancer Therapeutics (1137)

TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials. The company's patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.

TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials. The company's patented technology involves utilization of oncolytic viruses for enh...Show all

Company (Alive / Active)

Phone:

Fax:

Haartmaninkatu 3
4th Floor, C-Wing
Helsinki, 00290
Finland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
TILT Biotherapeutics $10.7M Dec 14, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related TILT Biotherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Enhanced adoptive cell therapy Nov 15, 2016 Application
Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto Mar 17, 2016 Application